Campa Cola is a soft drink brand in India and was popular in the 1970s. It disappeared from the market, but Mukesh Ambani's Reliance Group has recently revived it and is now set to be relaunched in the country.
The iconic cola beverage is making a comeback and reportedly coming to India once again this summer. It will return to the market in three different flavors - cola, lemon, and orange.
The relaunch comes after the Indian conglomerate purchased the Campa Cola brand from Pure Drinks in August of last year. The deal was valued at 220 million rupees or $2.7 million when it was closed.
In any case, the 50-year-old Campa Cola was once considered a rival of Coca-Cola. It enjoyed high popularity from the 1970s to the 1980s and only lost its shine in the 90s after more foreign soda brands landed in the Indian market. As per BBC News, the spokesperson of the Reliance Group told a local newspaper that they are hoping to inspire consumers of all generations so they will welcome the iconic brand.
Pure Drinks, the main bottler partner of Coca-Cola in India in the 70s, created Campa Cola after Coca-Cola pulled out of the country due to a change in government policies. At that time, the drink used the same font as the Coke brand, and it quickly established itself in the local market.
It was a homegrown soft drink that had become a favorite of the youths. Moreover, its ad tagline, "The Great Indian Taste," is still in the minds of many Indians up to this day.
"By presenting Campa in its new avatar, we hope to inspire consumers across generations to embrace this truly iconic brand and trigger a new excitement in the beverage segment," Reliance Group's spokesman told CNN News.
Photo by: Ernesto Rodriguez/Pixabay


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Thailand Inflation Remains Negative for 10th Straight Month in January
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 



